Bausch Health Expands YUN Skincare Collaboration to Mexico and EMEA Markets
Event summary
- Bausch Health and YUN are expanding their strategic collaboration to Mexico and additional EMEA markets, including the Czech Republic, Slovakia, Ukraine, Bulgaria, and Kazakhstan.
- The expansion follows the 2025 launch of YUN's eczema-prone skincare solutions in Poland, building on the 2024 launch of probiotic-based skincare solutions for acne-prone skin.
- YUN's skincare solutions are grounded in microbiome science, leveraging the YUN Probiotherapy™ technology platform.
- The rollout in Kazakhstan is expected to continue in October 2026.
The big picture
Bausch Health's expansion of its collaboration with YUN underscores the growing importance of microbiome science in dermatology. The move aligns with broader industry trends toward science-led, natural skincare solutions, positioning Bausch Health to capitalize on evolving consumer preferences. The strategic focus on EMEA and Mexico highlights the company's ambition to strengthen its presence in high-growth markets.
What we're watching
- Market Penetration
- How Bausch Health will leverage YUN's microbiome-focused approach to gain market share in emerging EMEA and Latin American markets.
- Product Differentiation
- Whether YUN's probiotherapeutical skincare solutions can sustain competitive advantage in the rapidly evolving dermatology sector.
- Regulatory Compliance
- The pace at which regulatory approvals will be secured in new markets, particularly in regions with stringent healthcare regulations.
Related topics